12-Month Lobbying Summary - Organization

Incyte Biosciences Canada Corporation / Christopher White, Associate Vice President & General Manager

Registration Summary

Currently active - Last Updated: 2026-05-01

Who is lobbying?

Incyte Biosciences Canada Corporation (Address & business activities)

Christopher White, Associate Vice President & General Manager

Senior Officer in previous versions
- Christine Lennon, General Manager Canada
- Thomas Tray, Treasurer

Government Funding

Did Incyte Biosciences Canada Corporation receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Incyte Biosciences Canada Corporation is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

Incyte Biosciences Canada Corporation has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Incyte Coporation (Address information)

Other Affiliates

The activities of Incyte Biosciences Canada Corporation are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Incyte Biosciences Canada Corporation:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocacy regarding changes to how innovative therapies are made accessible to patients residing in British Columbia.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Children and Families, Health, Hospitals, Indigenous Relations and Reconciliation, Industry
Discuss innovative agreements for reimbursement and the use of RWE in evaluation of pharmaceutical products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health, Hospitals, Science and Technology, Senior Citizens
Educate government stakeholders about life-science strategies and policies that impact access to innovative medicines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals, Senior Citizens
Educate on the unmet needs of rare cancers and how to facilitate improved processes within the government to allow for innovation in rare diseases.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology
Explain the need for expanded Next Generation Sequencing tests in order to provide innovative personalized cancer care to BC patients.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology
Identify changes to pharmaceutical legislation supporting appropriate government reimbursement of medicines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology, Senior Citizens
Raise awareness of the value that innovative medicines provide and demonstrate that Incyte Biosciences Canada supports the growth of the life-science sector in BC.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health, Hospitals, Science and Technology

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Member(s) of the BC Legislative Assembly
Office of the Premier
Parliamentary Secretary for Seniors' Services and Long-Term Care
Providence Health Care Society
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Matthew Bureau
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Sam Stankovic
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Christopher White
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Lobbyists in previous versions

In-house Lobbyists
Lobbyist	BC Former Public Office Holder Positions	Contributions
Cheryl Bielicz	Former Public Office Holder in BC: No	Contributions: No
Barry Flannelly	Former Public Office Holder in BC: No	Contributions: No
Christine Lennon	Former Public Office Holder in BC: No	Contributions: No

Registration number: 12180-4685
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

No monthly Lobbying Activity Reports have been submitted for the last 12 months.

View all Lobbying Activity Reports

Incyte Biosciences Canada Corporation - Address & business activities

Address:

2600 Alfred Nobel, Suite 301
Ville Saint Laurent, QC H4S 0A9
Canada

Contact information in previous versions
- 2600 Alfred Nobel, Suite 301
  Ville Saint Laurent, QC H4S 0A9
  Canada
- 6500 TransCanada Highway
  Suite 400
  Pointe Claire, QC H9R 0A5
  Canada

Description of Activities:
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 2500 people and have operations in the U.S., Canada, Europe and Japan.

Descriptions of the organization's activity in previous versions:
- Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Canada, Europe and Japan.

Date Modified:: 2026-05-08

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

Incyte Biosciences Canada Corporation / Christopher White, Associate Vice President & General Manager

Who is lobbying?

Incyte Biosciences Canada Corporation (Address & business activities)

Government Funding

Other Entities (working together for the purposes of lobbying) Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

Incyte Biosciences Canada Corporation / Christopher White, Associate Vice President & General Manager

Incyte Biosciences Canada Corporation (Address & business activities)

Government Funding

Other Entities (working together for the purposes of lobbying) Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Ministries/Provincial Entities

Incyte Biosciences Canada Corporation - Address & business activities

Incyte Biosciences Canada Corporation / Christopher White, Associate Vice President & General Manager

Incyte Coporation